Note 3 - Merger with Old Cytocom - Purchase Price - Assets Acquired and Liabilities Assumed (Details) - USD ($) |
Sep. 30, 2022 |
Dec. 31, 2021 |
Jul. 27, 2021 |
|---|---|---|---|
| Goodwill | $ 9,267,007 | $ 9,267,007 | |
| Cleveland BioLabs, Inc. [Member] | |||
| Cash and cash equivalents | $ 13,116,460 | ||
| Other receivables | 25,142 | ||
| Other current assets | 44,507 | ||
| Fixed assets - net | 4,954 | ||
| Panacela (67.57% ownership) | 178,388 | ||
| Total Tangible Assets | 13,369,451 | ||
| Accounts payable | (426,570) | ||
| Accrued expenses | (41,755) | ||
| Total Liabilities | (468,325) | ||
| Net Tangible Assets/Liabilities | 12,901,126 | ||
| Goodwill | 64,338,810 | ||
| Total Net Assets Acquired | $ 77,239,936 |
| X | ||||||||||
- Definition Amount of accrued liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date. No definition available.
|
| X | ||||||||||
- Definition The net amount of tangible assets (liabilities) acquired (assumed) at the acquisition date. No definition available.
|
| X | ||||||||||
- Definition The value of a subsidiary recognized as of the acquisition date. No definition available.
|
| X | ||||||||||
- Definition Amount of tangible assets acquired at the acquisition date. No definition available.
|
| X | ||||||||||
- Definition Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of liabilities assumed at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of property, plant, and equipment recognized as of the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|